Literature DB >> 18653098

Subclinical hypothyroidism in the elderly.

G Valenti1, A Fabbo.   

Abstract

Grade 2,3 and 4 hypothyroidism in the elderly, globally defined as subclinical hypothyroidism, is the object of this minireview. Attention is focused on the prevalence, on the causes and particularly on the clinical features that, in spite of the definition, frequently occur: these are summarized in cognitive impairment, mood disorders, lipid dysmetabolism, cardiovascular abnormalities. Finally a diagnostic algorithm is proposed for the selection of patients to be treated. The authors are of the opinion that a general screening with serum TSH assay for elderly hospitalized patients is worthwhile.

Entities:  

Year:  1996        PMID: 18653098     DOI: 10.1016/0167-4943(96)87003-8

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  3 in total

1.  Subclinical thyroid dysfunction and functional capacity among elderly.

Authors:  Vanessa S Virgini; Liselotte W Wijsman; Nicolas Rodondi; Douglas C Bauer; Patricia M Kearney; Jacobijn Gussekloo; Wendy P J den Elzen; J Wouter Jukema; Rudi G J Westendorp; Ian Ford; David J Stott; Simon P Mooijaart
Journal:  Thyroid       Date:  2013-11-13       Impact factor: 6.568

2.  Subclinical Thyroid Dysfunction and Frailty Among Older Men.

Authors:  Vanessa S Virgini; Nicolas Rodondi; Peggy M Cawthon; Stephanie Litwack Harrison; Andrew R Hoffman; Eric S Orwoll; Kristine E Ensrud; Douglas C Bauer
Journal:  J Clin Endocrinol Metab       Date:  2015-10-23       Impact factor: 5.958

3.  International variation in GP treatment strategies for subclinical hypothyroidism in older adults: a case-based survey.

Authors:  Wendy P J den Elzen; Anne A Lefèbre-van de Fliert; Vanessa Virgini; Simon P Mooijaart; Peter Frey; Patricia M Kearney; Ngaire Kerse; Christian D Mallen; Vera J C McCarthy; Christiane Muth; Thomas Rosemann; Audrey Russell; Henk Schers; David J Stott; Margot W M de Waal; Alex Warner; Rudi G J Westendorp; Nicolas Rodondi; Jacobijn Gussekloo
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.